• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

MedTech

cancer target detection radiopharma radio
MedTech

Labcorp adds to its suite of tests to detect cancer recurrence

Labcorp added to its suite of tests designed to detect cancer recurrence much earlier than traditional imaging and help drive treatment choices.
Joseph Keenan Jan 13, 2026 9:45am
blood test vial

Saga Diagnostics expands blood test to include colorectal cancer

Jan 13, 2026 8:55am
San Francisco bridge

JPM: Medtronic to 'step up' in M&A, exec says

Jan 13, 2026 8:50am
Jake Leach

Dexcom CEO outlines plan to stop a repeat of G7 supply shortage

Jan 13, 2026 8:10am
phoenix rising from the flames

Takeda leader says AI gave early-stage asset a 'phoenix' rebirth

Jan 13, 2026 6:16am
 Large layoffs of employees Wooden figures of people going to the exit

Lyra ditches sole rhinosinusitis asset, lays off all employees

Jan 13, 2026 4:30am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings